Paolo Pinton Lab__Signal Transduction

Home – Lab members – Research – Lab facilities – Publications – Selected Publications — Lab funds – Map – Contacts & Information

CURRICULUM VITAE ALESSANDRO RIMESSI

Date and place of birth: Ferrara (Italy), 17 march 1978  Nationality: Italian

Affiliation and official address: Dept. of Medical Sciences, University of Ferrara, Paolo Pinton's Lab, c/o CUBO Via Fossato di Mortara 70, 44121 Ferrara, Italy.

Telephone: +39 0532-455804 (office)  +39 0532-455807 (lab)

email: rmslsn@unife.it

ORCID n.: 0000-0001-7091-5765

EDUCATION
2002: Pharmaceutical Sciences degree (University of Ferrara)
2002: National Board (University of Ferrara)
2006: PhD in Molecular Medicine (University of Siena)

CAREER/EMPLOYMENT
1997-2000: Working experience in chemical laboratory “C.I.S.A.C” (Ferrara, Italy)
2006-2007: Research Fellow (University of Ferrara, Italy)
2008: Post Doctoral Research Scholar (Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA)
2008-2019: Assistant Professor of General Pathology (University of Ferrara, Italy)
2014: National Scientific Habilitation to the role of Associate Professor in the scientific field 06/A2 – General Pathology and Clinical Pathology.
2018: National Scientific Habilitation to the role of Associate Professor in the scientific field 06/A2 – General Pathology and Clinical Pathology.
2018: National Scientific Habilitation to the role of Full Professor in the scientific field 05/A2 – General Pathology and Clinical Pathology.
2018: National Scientific Habilitation to the role of Associate Professor in the scientific field 05/H2 – Histology.
2018: National Scientific Habilitation to the role of Associate Professor in the scientific field 06/N1 – Technology and methodology in medicine.
2019-present: Associate Professor of General Pathology (University of Ferrara, Italy)

RESEARCH EXPERIENCES
2008: UT Southwestern Medical Center, Simmons Cancer Center, Dallas, Texas, USA (MD PP Scaglioni).
2008-present: Member of the Interdepartmental Centre of Ferrara University for the study of diabetes.
2010-present: Member of the Laboratory for Technologies of Advanced Therapies (LTTA)
2013: The Queen’s Medical Center, Center for Biomedical Research, University of Hawaii, Honolulu, USA (MD R. Penner).
2016-2017: Member of “Animal Care and Use Commission” of University of Ferrara.
2016-2019: Elected Member of “Research Council” of University of Ferrara.
2019-present: Member of the Interdepartmental Centre of Ferrara University for Research and Innovative Therapies on Cystic Fibrosis

VALUTATION VQR RESULTS
VQR 2004-2010: Excellent
VQR 2011-2014: Excellent

PROFESSIONAL SOCIETIES
2008-present: Member of the Italian Society of Cell Biology and Differentiation (ABCD)
2018-present: Member of the National Institute for Nuclear Physics (INFN)

TEACHING EXPERIENCES
2008-2010: Course of General Pathology, in Chemical and Pharmaceutical Technologies degree, University of Ferrara, Italy.
2009-2010: Course of Molecular Pathology, in Biotechnology degree, University of Ferrara, Italy. 2010-2011: Course of General Pathology, in Pharmacy degree, University of Ferrara, Italy.
2011-2020: Course of General Pathology, in Chemical and Pharmaceutical Technologies degree, University of Ferrara, Italy.
2020-2021: Course of Clinical Pathology, in Medical Biotechnology degree, University of Ferrara, Italy.
2013-2020: Course of General Pathology, in Sciences of the Diagnostic Techniques of Health Professions Master course, University of Ferrara, Italy.
2008-present: Supervisor for Student degree and PhD students in several PhD Programs at the University of Ferrara, Italy.
- Member of the Doctoral Program in Molecular Medicine, University of Ferrara, Italy.

GRANTS
Principal Investigator: Local found "Bando FAR 2009" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2010" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2011" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2012" University of Ferrara, Italy.
2011-2015: Principal Investigator, “Ricerca Finalizzata, young researchers grant” of the Italian Ministry of Health, “Exploiting “oncogene addiction” and “premature senescence” to design novel therapeutic strategies for the treatment of cancer”, supported with 427130 euro.
2014-2017: Coordinator of unit, “Ricerca Finalizzata, young researchers grant” of the Italian Ministry of Health, “A combination of miR501-5p and mTOR as molecular markers for the prognosis of renal carcinomas”, supported with 108100 euro.
2015-2017: Principal Investigator, "Progetto FFC 20/2015" Fondazione Ricerca Fibrosi Cistica Onlus, “Mitochondrial quality control machinery a role in the P. aeruginosa-triggered inflammatory response in Cystic Fibrosis”, supported with 70000 euro.
Principal Investigator: Local found "Bando FAR 2016" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2017" University of Ferrara, Italy.
2017: Principal Investigator: Local found in support to research “FIR2017” University of Ferrara
2017-2020: Principal Investigator: “Ricerca Finalizzata, young researchers grant” of the Italian Ministry of Health, “Analysis of the modulation of the MCU complex expression and activity in stomach and colorectal cancers”, supported with 367830 euro.
Principal Investigator: Local found "Bando FAR 2018" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2019" University of Ferrara, Italy.
2019-2021: Unit Coordinator, “Bando PRIN2017-Research Projects of National Relevance” of the Italian Ministry of Education, University and Research, “A shape to fit the needs: how cells rearrange their organelle composition and architecture during development and stress”, supported with 178250 euro.
Principal Investigator: Local found "Bando FAR 2019" University of Ferrara, Italy.
Principal Investigator: Local found "Bando FAR 2020" University of Ferrara, Italy.

AWARDS
2003: Telethon Fellowship
2004: Winner of the "Best Poster" annual prize of the Italian Society of Cell Biology and Differentiation (ABCD)
2008: International Human Frontier Science Program, Fellowship

EDITORIAL ACTIVITY

Prof. Rimessi is Editor board member for Frontiers in Oncology, Frontiers in Cell and Developmental Biology and for Biomedicines.
Prof. Rimessi routinely acts as reviewer for international scientific journals (Nature Communications, Cell Death and Differentiation, Cell Calcium, BBA, Molecular & Cellular Oncology, Cellular Physiology and Biochemistry, Frontiers Oncology, Cell Death and Disease).

- Referee for the ANVUR VQR 2011-14.

Reviewer for the call for proposal:

-“Blue Sky Research” of University of Pavia, Italy.

-“Joint Project 2017” of University of Verona, Itay.

-“Call competitive project 2017” University of Firenze, Italy.

MAIN RESEARCH ACTIVITIES

Alessandro Rimessi has obtained a degree in Pharmacy and a PhD in molecular medicine in one of the best cell biology laboratory in Italy. During his undergraduate laboratory work he has studied the role of Protein Kinase C (PKC) in oxidative stress and in his graduate work: the role of some calcium effectors in apoptosis induction. The outstanding quality of his work led him to obtain the “International Human Frontier Science Program, long-term fellowships award” in addition to an outstanding publication record. His current projects are focused to:

- Understanding the role of particular isoform of PKC in chemoresistance and of specific oncogene or oncosuppressor in tumor maintenance.

- Understanding the role of mitochondrial quality control machinery to decode the pro-inflammatory signals in Cystic Fibrosis.

At today, Prof.. Rimessi has acquired expertise in mitochondrial stress responses (autophagy/UPR/apoptosis), molecular and cell biology, biochemistry, Ca²⁺ signaling, cancer biology and digital imaging.

PUBLICATIONS (at June 2021)
68 papers in international “peer-review” journals, of which 23 papers as first/last/corresponding author, and more than 30 meeting abstracts:

Total impact factor: 345 (Active IF 154: 115 from original research article and 39 from review)

Total citation index (Scopus): 3986

Total citation index (Google Scholar): 6027

Total citation index (ISI WEB): 3654

H index (Scopus): 32

H index (Google Scholar): 35

H index (ISI WEB): 32

LIST OF PUBLICATIONS

Scopus: https://www.scopus.com/authid/detail.uri?authorId=57190973922

ISI WEB: https://app.webofknowledge.com/author/record/756521